|
IES20180094A2
|
|
Drug intermediates o-aminobenzaldehyde synthesis method
|
|
IES20180110A2
|
|
Medicine intermediates 2,4-difluorobenzoic acid synthesis method
|
|
IES20180114A2
|
|
Rivanol medicine intermediates 2-chloro-4-nitrobenzoic acid synthesis
|
|
IES86997B2
|
|
Medicine intermediates sulfanilic acid synthesis method
|
|
IES20180095A2
|
|
Organic synthesis intermediates 2-aminobenzothiazole synthesis method
|
|
IES86949B2
|
|
Medicine intermediates o-aminobiphenyl synthesis method
|
|
IES86998B2
|
|
Drugs intermediates m-amionbenzoic acid synthesis method
|
|
IES20180096A2
|
|
Organic synthesis intermediates m-aminobenzenesulfonic acid synthesis method
|
|
IES87019B2
|
|
Pyranzinamide drug intermediates p-diazabenzene-2,3-dicarboxylic acid synthesis method
|
|
IES86947B2
|
|
Blood circulation diagnosis medication o-sulfonamide benzoic acid synthesis method
|
|
IES87001B2
|
|
Organic synthesis intermediates N-propenyl urea synthesis method
|
|
IES20180115A2
|
|
Antagonists medicine intermediates o-nitrobenzoic acid synthesis method
|
|
IES20180092A2
|
|
Polyester fiber dyeing modifier isophthalic acid synthesis method
|
|
IES20180106A2
|
|
Drugs intermediates 2-formylcarbonylbenzoic acid synthesis method
|
|
IES87000B2
|
|
Drug intermediates aluminium isopropoxide synthesis method
|
|
IES20180099A2
|
|
Drugs intermediates o-aminobenzoic acid synthesis method
|
|
IES20180111A2
|
|
Antimalarial medicine intermediates 2,4-diclorobenzoic acid synthesis
|
|
GB201705348D0
|
|
Drug intermediates o-aminobenzaldehyde synthesis method
|
